GTBPVSVHC• 7 Days (Normalized)
GTBP vs VHC (GT Biopharma Inc. vs VirnetX Holding Corp)
Showing Closing Date Range from Sep 25 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $6.1
-11.47%
GT Biopharma Inc.
Normalized Baseline0.00%
VHC Performance $10.48
+1.16%
VirnetX Holding Corp
Normalized Baseline0.00%
Alpha Spread Margin VHC LEADS
-12.63 pts
VHC outperforming by 12.63 percentage points
GTBPVHC
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP VHC
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(5 dates)
| Date | GTBP Price | GTBP Gain (%) | VHC Price | VHC Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $6.10 | -11.47% | $10.48 | +1.16% | -12.63% |
| Sep 30, 2026 | $- | $10.19 | -1.64% | - | |
| Sep 29, 2026 | $6.88 | -0.22% | $- | - | |
| Sep 28, 2026 | $6.80 | -1.31% | $10.23 | -1.25% | -0.06% |
| Sep 25, 2026 | $6.89 | +0.00% | $10.36 | +0.00% | +0.00% |